找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical and Preclinical Models for Maximizing Healthspan; Methods and Protocol Paul C. Guest Book 2020 Springer Science+Business Media, LL

[復(fù)制鏈接]
樓主: retort
31#
發(fā)表于 2025-3-26 22:00:29 | 只看該作者
32#
發(fā)表于 2025-3-27 03:11:19 | 只看該作者
https://doi.org/10.1007/978-3-030-77935-1xide in sorafenib-treated HCC cells under the influence of fibroblast growth factor 19 expression levels. Here we present protocols to highlight the utility of electrochemical strategies in drug and gene studies.
33#
發(fā)表于 2025-3-27 05:47:29 | 只看該作者
The Impact of New Biomarkers and Drug Targets on Age-Related Disordersd databases containing relevant information. Such efforts will support future interdisciplinary studies and help to identify potential new targets that are amenable to therapeutic approaches such as pharmacological interventions to increase the human healthspan in parallel with the lifespan.
34#
發(fā)表于 2025-3-27 11:44:13 | 只看該作者
Protocol for the Use of the Ketogenic Diet in Preclinical and Clinical Practiceally, more detailed studies on the mechanism of action are necessary to help identify potential biomarkers for response prediction and monitoring, and to uncover new drug targets to aid the development of novel treatments.
35#
發(fā)表于 2025-3-27 16:37:19 | 只看該作者
36#
發(fā)表于 2025-3-27 20:08:14 | 只看該作者
37#
發(fā)表于 2025-3-28 01:09:01 | 只看該作者
1064-3745 expertsThis book presents a series of protocols in multiple disease areas affected by the aging process along with several methods which have shown progress in nutrient- or intervention-based approaches to maximize the healthspan. Of interest to researchers in the areas of chronic disease, gerontol
38#
發(fā)表于 2025-3-28 02:48:35 | 只看該作者
39#
發(fā)表于 2025-3-28 09:25:49 | 只看該作者
40#
發(fā)表于 2025-3-28 10:40:05 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-16 03:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
格尔木市| 孝昌县| 大新县| 苗栗市| 松阳县| 德清县| 巴彦县| 襄垣县| 池州市| 望奎县| 松桃| 隆德县| 廉江市| 泽州县| 杨浦区| 永新县| 突泉县| 从化市| 襄汾县| 四会市| 宣化县| 黄山市| 大关县| 云阳县| 行唐县| 信宜市| 德江县| 喀什市| 齐齐哈尔市| 铁岭县| 遂川县| 通山县| 普兰县| 临城县| 横山县| 钦州市| 尼勒克县| 汝州市| 晋宁县| 西贡区| 盘锦市|